Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 497-503

  Grunewald, Virginie ^a   Bonnet, Mathilde ^a   Boutin, Sylvie ^a   Yip, Timothy ^b   Louzir, Hechmi ^c   Levrero, Massimo ^d   Seigneurin, Jean Marie ^e   Raphael, Martine ^f   Touitou, Robert ^a   Martel Renoir, Dominique ^a   Cochet, Chantal ^a   Durandy, Anne ^g   Andre, Patrice ^h   Lau, W ^b   Zeng, Yi ⁱ   Joab, Irène ^a  

^a CNRS   (France)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f AVICENNE HOSPITAL   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

ⁱ Institute of Virology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; GENE PRODUCT; LEUCINE ZIPPER PROTEIN; SERINE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; ASIA; CONTROLLED STUDY; DIMERIZATION; EPSTEIN BARR VIRUS; EUROPE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; NASOPHARYNX CARCINOMA; NORTH AFRICA; PRIORITY JOURNAL; PROTEIN DOMAIN; TAIWAN; TUMOR BIOPSY;

AFRICA, NORTHERN; AMINO ACID SEQUENCE; CARCINOMA; DNA-BINDING PROTEINS; EUROPE; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE DELETION; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0032498631     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<497::AID-IJC2>3.0.CO;2-O     Document Type: Article

References (25)

1. ARRAND, J.R., YOUNG, L.S. and TUGWOOD, J.D., Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J. Virol., 631, 983-986 (1989).
2. 1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barrvirus transactivator Zta. J. biol. Chem., 271, 31799-31802 (1996)
3. CHANG, Y., CHEN, M.I., WU, R., CHANG, P., SHU, C. and LIU, S., Sequence analysts of the BZLF1 gene of Epstein-Barr virus derived from a new variant isolated in Taiwan. Nucleic Acids Res., 20, 139 (1992).
4. CHEN, H.L., LUNG, M.L., CHAN, K.H., GRIFFIN, B.E. and NG, M.H., Tissue distribution of Epstein-Barr-virus genotypes. J. Virol., 70, 7301-7305 (1996).
5. CHEN, M.L., TSAI, C.N., LIANG, C.L., SHU, C.H., HUANG, C.R., SULITZEANU, D., LIU, S.T. and CHANG, Y.S., Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr-virus variant derived from nasopharyngeal carcinoma in the Taiwanese population. Oncogene, 7, 2131-2140 (1992).
6. COCHET, C., MARTEL-RENOIR, D., GRUNKWALD, V., BOSQ, J., COCHET, G., SCHWAAB, G., BERNAUDIN, J.F. and JOAB, I., Expression of the Epstein-Barrvirus immediate-early gene. BZLF1 in nasopharyngeal-carcmoma tumor cells. Virology, 197, 358-365 (1993).
7. FLEMINGTON, E. and SPECK, S.H., Evidence forcoiled-coil dimer formation by an Epstein-Barr-virus transactivator that lacks a heptad repeat of leucine residues. Proc. nat. Acad. Sci. (Wash.), 87, 9459-9463 (1990).
8. FRANCIS, A.L., GRADOVILLE, L. and MILLER, G., Alteration of a single serine in the basic domain of the Epstein-Barr-virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J. Virol., 71, 3054-3061 (1997).
9. GUTSCH, D.E., HOLLEYGUTHRIE, E.A., ZHANG, Q., STEIN, B., BLANAR, M.A., BALDWIN, A.S. and KENNEY, S.C., The B-Zip transactivator of Epstein-Barr virus. BZLF1 functionally and physically interacts with the p65 sub-unit of NF-kappa b. Mol. cell. Biol., 14, 1939-1948 (1994).
10. HU, L.F., CHEN, F., ZHENG, X., ERNBERG, I., CAO, S.L., CHRISTENSSON, B., KLEIN, G. and WINBERG, G., Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein LMP1. Oncogene, 8, 1575-1583 (1993).
11. HU, L.F., ZABAROVSKY, E.R., CHEN, F., CAO, S.L., ERNBERG, I., KLEIN, G. and WINBERG, G., Isolation and sequencing of the Epstein-Barr-virus BZLF1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. gen. Virol., 72, 2399-2409 (1991).
12. KHANIM, F., YAO, Q.Y., NIEDOBITEK, G., SIHOTA, S., RICKINSON, A.B. and YOUNG, L.S., Analysis of Epstein-Barr-virus-gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood, 88, 3491-3501 (1996).
13. KNECHT, H., BACHMANN, E., BROUSSET, P., SANDVEJ, K., NADAL, D., BACHMANN, F., ODERMATT, B.F., DELSOL, G. and PALLESEN, G., Deletions within the IMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood, 82, 2937-2942 (1993).
14. LAU, R., PACKHAM, G. and FARELL, P.J., Differential splicing of Epstein-Barrvirus immediate-early RNA. J. Virol., 66, 6233-6236 (1992).
15. LUNG, M.L., LAM, W.P., SHAM, J., CHOY, D., YONG-SHENG, Z., GUO, H.Y. and NG, M.H., Detection and prevalence of the "f " variant of Epstein-Barrvirus in Southern China. Virology, 185, 67-7) (1991).
16. MILLER, W.E., EDWARDS, R.H., WALLING, D.M. and RAABTRAUB, N., Sequence variation in the Epstein-Barr-virus latent membrane protein 1. J. gen. Virol., 75, 2729-2740 (1994).
17. PACKHAM, G., BRIMMELL, M., COOK, D., SINCLAIR, A.J. and FARRELL, P.J., Strain variation in Epstein-Barr-virus immediate-early genes. Virology, 192, 541-550 (1993).
18. RICKINSON, A.B. and KIEFF, E., Epstein-Barr virus. In: B.N. Fields. Knipe, D.M. and A.L. HOWLEY ET (EDS.), VIROLOGY, PP. 2397-2446, LIPPINCOTT-RAVEN PRESS, PHILADELPHIA (1996).
19. ROWE, M., YOUNG, L.S., CADWALLADER, K., PETTI, L., KIEFF, E. and RICKINSON, A.B., Distinction between Epstein-Barr-virus-type-A(EBNA2A) and type-B(EBNA-2B) isolates extends to the EBNA-3 family of nuclear proteins. J. Virol., 63, 1031-1039 (1989).
20. SANDVEJ, K., PEH, S.C., ANDRESEN, B.S. and PALLESEN, G., Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barrvirus(EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood, 84, 4053-4060 (1994).
21. SISTA, N.D., PAGANO, J.S., LIAO, W. and KENNEY, S., Retinoic acid is a negative regulator of the Epstein-Barr-virus protein (BZLF1) that mediates disruption of latent infection. Proc. nat. Acad. Sci. (Wash.), 90, 3894-3898 (1993).
22. SNUDDEN, D.K., SMITH, P.R., LAI, D., NG, M.H. and GRIFFIN, B.E., Alterations in the structure of the EBV nuclear antigen, EBNA1. in epithelial-cell tumors. Oncogene, 10, 1545-1552 (1995).
23. WALLING, D.M., EDMISTON, S.N., SIXBEY, J.W., ABDEL-HAMID, M., RESNICK, L. and RAAB-TRAUB, N., Co-infection with multiple strains of the Epstein-Barr virus in human-immunodeficiency-virus-associated hairy leukoplakia. Proc. nat. Acad. Sci. (Wash.), 89, 6560-6564 (1992).
24. WRIGHTHAM, M.N., STEWART, J.P., JANJUA, N.J., PEPPER, S.D., SAMPLE, C., ROONEY, C.M. and ARRAND, J.R., Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr-virus nuclear antigen EBNA-1. Virology, 208, 521-530 (1995).
25. ZHANG, Q., GUTSCH, D. and KENNRY, S., Functional and physical interaction between p53 and BZLF1-implications for Epstein-Barr-virus latency. Mol. cell. Biol., 14, 1929-1938 (1994)